← Eichor
Study identifier: NCT03437486 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Mechanisms of Familial Pulmonary Fibrosis

Condition: Familial Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis · Familial Interstitial Pneumonia  ·  Sponsor: Vanderbilt University Medical Center

PhaseN/A
Planned participants750
Who can joinAll sexes, 40 Years to 75 Years
Healthy volunteersNo

About this study

This a prospective, longitudinal study of first-degree family members of patients diagnosed with familial interstitial pneumonia (FIP). FIP is the familial form of idiopathic pulmonary fibrosis (IPF), which is defined as 2 or more bloodline relatives which have a diagnosis of idiopathic interstitial pneumonia (IIP). The most common form of idiopathic interstitial pneumonia in FIP families is IPF (approximately 70%). The inheritance pattern in FIP is consistent with autosomal dominant inheritance with incomplete penetrance. Therefore, individuals in this study have approximately 50% risk of carrying a disease-associated allele. The causative gene is currently only known approximately 20% of families. The main goal of this longitudinal study is to better establish the natural history of FIP and to identify risk factors for later development of symptomatic disease. The investigators' plan is to follow these at-risk individuals with yearly questionnaires and planned in person 2 year follow-ups through age 75 or until they develop symptomatic FIP.

This description comes directly from the study's public registry record.

Talk to the study team

Tisra H Fadely, BSN, RN  ·  Tisra.h.fadely@vumc.org

Cheryl Markin, BS  ·  cheryl.markin@vumc.org

Always discuss trial participation with your own doctor first.

Locations (1)

Vanderbilt University Medical CenterNashville, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03437486